LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p

Table 1

Relationship between MBNL1-AS1 and clinicopathological characteristics of PAAD.

Characteristics	N	(%)	MBNL1-AS1		χ^2
			Low (n = 24)	High (n = 28)
Age					1.784	0.182
<65	23	44.23	13	10
≥65	29	55.77	11	18
Gender					0.119	0.730
Man	29	55.77	14	15
Female	23	44.23	10	13
Tumor location					0.197	0.657
Head	33	63.46	16	17
Body and tail	19	36.54	8	11
Differentiated degree					5.175	0.023
Well	24	46.15	7	17
Moderate-poor	28	53.85	17	11
TNM stage					4.924	0.026
I-II	38	73.08	14	24
III-IV	14	26.92	10	4
Lymph node metastasis					9.095	0.003
Negative	29	55.77	8	21
Positive	23	44.23	16	7
Alcohol history					0.550	0.458
Negative	21	40.38	11	10
Positive	31	59.62	13	18